Marshall Wace, LLP Enovis Corp Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Enovis Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 9,227 shares of ENOV stock, worth $413,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,227Holding current value
$413,738% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ENOV
# of Institutions
308Shares Held
58.3MCall Options Held
1.67MPut Options Held
538K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.59MShares$295 Million0.25% of portfolio
-
Black Rock Inc. New York, NY5.33MShares$239 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$219 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.19MShares$143 Million0.05% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH2.43MShares$109 Million0.62% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.43B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...